awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36171531-29BC7E98-9AC1-4235-91FF-7DD2C3E1E6D3
Q36171531-29BC7E98-9AC1-4235-91FF-7DD2C3E1E6D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36171531-29BC7E98-9AC1-4235-91FF-7DD2C3E1E6D3
Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study
P2860
Q36171531-29BC7E98-9AC1-4235-91FF-7DD2C3E1E6D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36171531-29BC7E98-9AC1-4235-91FF-7DD2C3E1E6D3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9461eb1234a8fe98320a9389f9e94d33f8d18f16
P2860
Cost-effectiveness of glatiramer acetate and interferon beta-1a for relapsing-remitting multiple sclerosis, based on the CombiRx study.